Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
10.3349/ymj.2016.57.6.1329
- Author:
Minh Cong NGUYEN
1
;
Jong Taek PARK
;
Yeong Gwan JEON
;
Byeong Hwa JEON
;
Kwang Lae HOE
;
Young Myeong KIM
;
Hyun Kyo LIM
;
Sungwoo RYOO
Author Information
1. Department of Biology, College of Natural Sciences, School of Medicine, Kangwon National University, Chuncheon, Korea. ryoosw08@kangwon.ac.kr
- Publication Type:Original Article
- Keywords:
Peroxynitrite;
arginase inhibition;
endothelial nitric oxide synthase phosphorylation;
endothelial dysfunction;
nitric oxide;
L-arginine
- MeSH:
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;
Acetylcholine;
Arginase*;
Arginine;
Blotting, Western;
Endothelium;
Human Umbilical Vein Endothelial Cells;
NG-Nitroarginine Methyl Ester;
Nitric Oxide;
Nitric Oxide Synthase Type III*;
Oxidation-Reduction;
Peroxynitrous Acid;
Phosphorylation*;
Reactive Oxygen Species
- From:Yonsei Medical Journal
2016;57(6):1329-1338
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Peroxynitrite plays a critical role in vascular pathophysiology by increasing arginase activity and decreasing endothelial nitric oxide synthase (eNOS) activity. Therefore, the aims of this study were to investigate whether arginase inhibition and L-arginine supplement could restore peroxynitrite-induced endothelial dysfunction and determine the involved mechanism. MATERIALS AND METHODS: Human umbilical vein endothelial cells (HUVECs) were treated with SIN-1, a peroxynitrite generator, and arginase activity, nitrite/nitrate production, and expression levels of proteins were measured. eNOS activation was evaluated via Western blot and dimer blot analysis. We also tested nitric oxide (NO) and reactive oxygen species (ROS) production and performed a vascular tension assay. RESULTS: SIN-1 treatment increased arginase activity in a time- and dose-dependent manner and reciprocally decreased nitrite/nitrate production that was prevented by peroxynitrite scavenger in HUVECs. Furthermore, SIN-1 induced an increase in the expression level of arginase I and II, though not in eNOS protein. The decreased eNOS phosphorylation at Ser1177 and the increased at Thr495 by SIN-1 were restored with arginase inhibitor and L-arginine. The changed eNOS phosphorylation was consistent in the stability of eNOS dimers. SIN-1 decreased NO production and increased ROS generation in the aortic endothelium, all of which was reversed by arginase inhibitor or L-arginine. N(G)-Nitro-L-arginine methyl ester (L-NAME) prevented SIN-1-induced ROS generation. In the vascular tension assay, SIN-1 enhanced vasoconstrictor responses to U46619 and attenuated vasorelaxant responses to acetylcholine that were reversed by arginase inhibition. CONCLUSION: These findings may explain the beneficial effect of arginase inhibition and L-arginine supplement on endothelial dysfunction under redox imbalance-dependent pathophysiological conditions.
